How Aegis Is Solving the Rare Disease Clinical Trial Matching Problem with AI
400 million people live with rare diseases worldwide, yet fewer than 5% ever participate in a clinical trial. Aegis is the AI-powered matching platform that connects rare disease patients with the trials that could save their lives.